Ardelyx, Inc. Files 8-K: Operations & Financials Update
Ticker: ARDX · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1437402
| Field | Detail |
|---|---|
| Company | Ardelyx, Inc. (ARDX) |
| Form Type | 8-K |
| Filed Date | Jan 13, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $54 million, $158 million, $57 million, $161 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financials, reporting
Related Tickers: ARDX
TL;DR
ARDX filed an 8-K for ops/financials & other events - check for details.
AI Summary
Ardelyx, Inc. filed an 8-K on January 13, 2025, reporting on its results of operations, other events, and financial statements. The filing does not contain specific financial figures or details about the 'other events' but serves as a notification of these items.
Why It Matters
This 8-K filing indicates that Ardelyx, Inc. is providing updates on its operational results and financial condition, which is important for investors to monitor the company's performance.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting operational and financial updates without disclosing specific material events or changes.
Key Players & Entities
- ARDELYX, INC. (company) — Registrant
- January 13, 2025 (date) — Date of Report
- 001-36485 (company) — SEC File Number
- 26-1303944 (company) — IRS Employer Identification Number
- 400 FIFTH AVE. , SUITE 210 , WALTHAM , MA 02451 (address) — Principal Executive Offices
- ( 510 ) 745-1700 (phone_number) — Registrant's telephone number
FAQ
What specific results of operations are being reported by Ardelyx, Inc. in this 8-K?
The filing indicates that results of operations are being reported, but the specific details are not provided within the text of the 8-K itself, suggesting they may be in attached exhibits or a separate press release.
What are the 'Other Events' mentioned in the 8-K filing?
The filing lists 'Other Events' as an item being reported, but the nature of these events is not detailed in the provided text.
When was this 8-K report filed by Ardelyx, Inc.?
The 8-K report was filed on January 13, 2025.
What is the principal executive office address for Ardelyx, Inc.?
The principal executive offices are located at 400 FIFTH AVE., SUITE 210, WALTHAM, MA 02451.
Does this 8-K filing contain specific financial statements?
Yes, the filing indicates that 'Financial Statements and Exhibits' are part of this 8-K report.
Filing Stats: 597 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2025-01-13 08:04:44
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 ARDX The Nasdaq Global Market Indicat
- $54 million — of IBSRELA (tenapanor) of approximately $54 million for the fourth quarter ended December 3
- $158 million — ed December 31, 2024, and approximately $158 million for the full year ended December 31, 20
- $57 million — of XPHOZAH (tenapanor) of approximately $57 million for the fourth quarter ended December 3
- $161 million — ed December 31, 2024, and approximately $161 million for the full year ended December 31, 20
- $250 m — short-term investments of approximately $250 million, unaudited. These amounts are p
Filing Documents
- ardx-20250113.htm (8-K) — 27KB
- ardx-20250113_g1.jpg (GRAPHIC) — 3KB
- 0001628280-25-001246.txt ( ) — 157KB
- ardx-20250113.xsd (EX-101.SCH) — 2KB
- ardx-20250113_lab.xml (EX-101.LAB) — 22KB
- ardx-20250113_pre.xml (EX-101.PRE) — 13KB
- ardx-20250113_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On January 13, 2025, Ardelyx, Inc. (the "Company") announced: Unaudited U.S. net product sales revenue of IBSRELA (tenapanor) of approximately $54 million for the fourth quarter ended December 31, 2024, and approximately $158 million for the full year ended December 31, 2024. Unaudited U.S. net product sales revenue of XPHOZAH (tenapanor) of approximately $57 million for the fourth quarter ended December 31, 2024, and approximately $161 million for the full year ended December 31, 2024. The Company also announced that as of December 31, 2024, it had cash, cash equivalents, and short-term investments of approximately $250 million, unaudited. These amounts are preliminary and are subject to adjustment in connection with preparation of audited financial statements. As a result, these amounts may differ materially from the amounts that will be reflected in the Company's financial statements for the year ended December 31, 2024. The preliminary financial data included in this Current Report on Form 8-K has been prepared by, and is the responsibility of, the Company's management. Ernst & Young LLP has not audited, reviewed, examined, compiled, nor applied agreed-upon procedures with respect to the preliminary financial data. Accordingly, Ernst & Young LLP does not express an opinion or any other form of assurance with respect thereto.
01 Other Information
Item 8.01 Other Information The information set forth in Item 2.02 is incorporated into this Item 8.01 by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 13, 2025 ARDELYX, INC. By: /s/ Justin Renz Justin Renz Chief Financial and Operations Officer